StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. A number of other research firms have also issued reports on ALNY. Morgan Stanley reduced their price target on shares of Alnylam Pharmaceuticals from $184.00 to $176.00 and set an […]
StockNews.com downgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday. A number of other research analysts have also recently commented on ALNY. William Blair restated an outperform rating on shares of Alnylam Pharmaceuticals in a research note on Monday, January 8th. […]
Cantor Fitzgerald restated their neutral rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $165.00 price target on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on ALNY. JPMorgan Chase & Co. boosted their target price on […]
Alnylam Pharmaceuticals (NASDAQ:ALNY) Rating Reiterated by Royal Bank of Canada themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald reiterated their neutral rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report issued on Tuesday morning, Benzinga reports. The brokerage currently has a $165.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on ALNY. Needham & Company LLC reiterated a buy […]